Previous 10 | Next 10 |
2024-02-01 12:36:09 ET More on Mid-day movers & stocks. Nextracker Inc. 2024 Q3 - Results - Earnings Call Presentation Nextracker Inc. (NXT) Q3 2024 Earnings Call Transcript Nextracker Inc.: Riding The Solar Power Tide While Growing Profitably Nextracker ...
— Blinded data from the ongoing Phase 2 clinical trial of BRTX-100 to be described in poster presentation — — Company to host webcasted conference call to review data on February 5, 2024 at 8:30am EST — MELVILLE, N.Y., Feb. 01, 2024 (GLOBE NEWSWIRE) -- ...
2023-12-12 09:47:22 ET More on BioRestorative Therapies, Inc. Seeking Alpha’s Quant Rating on BioRestorative Therapies, Inc. Historical earnings data for BioRestorative Therapies, Inc. Financial information for BioRestorative Therapies, Inc. For furthe...
--Notice of allowance will be the fourth U.S. patent granted under Company’s ThermoStem ® program targeting obesity and metabolic disorders, including type 2 diabetes-- MELVILLE, N.Y., Dec. 12, 2023 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc ...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
BioRestorative Therapies Inc (BRTX) is expected to report $-0.68 for Q3 2023
MELVILLE, NY., Oct. 09, 2023 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRetorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, announced today that Company CEO, Lance Alstodt, has been invited to pres...
2023-09-18 10:44:36 ET More on BioRestorative Therapies, Inc. Seeking Alpha’s Quant Rating on BioRestorative Therapies, Inc. Historical earnings data for BioRestorative Therapies, Inc. Financial information for BioRestorative Therapies, Inc. BioRestora...
MELVILLE, NY / ACCESSWIRE / September 18, 2023 / BioRestorative Therapies Inc. (NASDAQ:BRTX) ("BioRestorative") is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions such as obesity and diabetes. The company is...
-- BioRestorative to Leverage its Core Competencies in Cell Biology and Manufacturing to S upply B iologics for C osmetic A pplications in Strategic Agreement --Agreement Represents Initial Venture in to the $62.8 B ...
News, Short Squeeze, Breakout and More Instantly...
BioRestorative Therapies Inc Company Name:
BRTX Stock Symbol:
OTCMKTS Market:
- New journal section will focus on emerging and translation work in the field of regenerative medicine - MELVILLE, N.Y., July 23, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: ...
– Adds to comprehensive patent portfolio underlying novel ThermoStem ® technology platform – – Expanding intellectual property estate expected to help drive ThermoStem ® licensing opportunities – – Substantive di...
- Significant YoY improvement in operating performance - - Ends Q1-2024 with $16.4 million cash, cash equivalents, and marketable securities - MELVILLE, N.Y., June 17, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX ...